|
1. Hernandez D, Trinanes J, Maria Armas A, Ruizesteban P, Alonsotitos J, Duarte A, et al. Vascular damage and kidney transplant outcomes: an unfriendly and harmful link. Am J Med Sci 2017; 354:7-16. doi.10.1016/j.amjms.2017.01.004. 2. Baroletti S, Bencivenga GA, Gabardi S. Treating gout in kidney transplant recipients. Prog Transplant2004; 14:143–147. doi.10.7182/prtr.14.2. dr3j76l1603k0145 3. Kim KM, Kim SS, Han DJ, Yang WS, Park JS, Park SK. Hyperuricemia in kidney transplant recipients with intact graft function. Transplant Proc2010; 42: 3562-7. doi.10.1016/j.transproceed.2010.07.104. 4. Mazzali M. Uric acid and transplantation. Semin Nephrol2005; 25: 50-5. doi.10.1016/j.semnephrol.2004.09.008. 5. Lin HY, Rocher LL, Mcquillan MA, Schmaltz S, Palella TD, Fox IH. Cyclosporin induced hyperuricemia and gout. N Engl J Med1989; 321:287-92. doi.10.1056/NEJM198908033210504. 6. West C, Carpenter BJ, Halaka TR. The incidence of gout in renal transplantation. Am J Kid Dis1987; 10:369-72. doi.10.1016/s0272-6386(87)80103-8. 7. Wang JG, Staessen JA, Fagard RH, Birkenhager WH, Gong L, Liu L. Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension 2001; 37:1069-74. doi.10.1161/01.hyp.37.4.1069. 8. Gerhardt U, Grobe Huttman M, Hohage H. Influence of hyperglycemia and hyperuricemia on long‐term transplant survival in kidney transplant patients. Clin Transplant 1999; 13:375-9. doi.10.1034/j.1399-0012.1999.130502. x. 9. Bandukwala F, Huang M, Zaltzman JS, Nash MM, Prasad GV. Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk. Am J Cardiol 2009; 103:867-871. doi.10.1016/j.amjcard.2008.11.042. 10. Mazzali M, Kim YG, Suga S, Gordon KL, Kang DH, Jefferson JA et al. Hyperuricemia exacerbates chronic cyclosporin nephropathy. Transplantation 2001; 71:900-5. doi.10.1097/00007890-200104150-00014. 11. Filiopoulos V, Hadjiyannakos D, Vlassopoulos D. New insights into uric acid effects on the progression and prognosis of chronic kidney disease. Ren Fail 2012; 34:510-20. doi.10.3109/0886022X.2011. 653753. 12. Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase2. Hypertension 2003; 41:1287-93. doi.10.1161/01.HYP.0000072820.07472.3B. 13. deFilippi C, Wasserman S, Rosanio S, Tiblier E, Sperger H, Tocchi M, et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long term hemodialysis. JAMA 2003; 290:353-9. doi.10.1001/jama.290.3.353. 14. kang D, Park S, Lee I, Johnson R. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol2005; 16:3553-62. doi: 10.1681/ASN.2005050572. 15. Golmohammadi S, Almasi A, Manouchehri M, Omrani HR, Zandkarimi MR. An Allopurinol against progression of chronic kidney disease. Iran J Kid Dis 2017; 11:286-293. 16. Einollahi B, Einollahi H, Nafar M, Rostami Z. Prevalence and risk factors of hyperuricemia among kidney transplant recipients. Indian J Nephrol 2013; 23: 201-5. doi.10.4103/0971-4065.111849. 17. Bandukwala F, Huang M, Prasad GV. Role of uric acid in post renal transplantation human vascular cells. Transplant Proc 2009; 41: 1634-6. doi.10.1016/j.transproceed. 2009.01.098. 18. Kanbay M, Akcay A, Huddam B, Usluogullari CA, Arat Z, Ozdemir FN et al. Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients. Transplant Proc 2005; 37: 3119-20. doi.10.1016/j.transproceed.2005.08.042. 19. Zhang K, Gao B, Wang Y, Wang G, Wang W, Zhu Y et al. Serum uric acid and renal transplantation outcomes: at least 3-year post-transplant retrospective multivariate analysis. PLos One 2015; 10: 0133834. doi.10.1371/journal.pone.0133834.
|
